30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Stuart Arbuckle

Track

Insider profile

Currently holds positions in Rhythm Pharmaceuticals Inc, Vertex Pharmaceuticals Inc and ImmunoGen Inc

Positions

Position Company Period
Director Rhythm Pharmaceuticals Inc July 24, 2019 -
Executive Vice President, Chief Commercial Officer Vertex Pharmaceuticals Inc Sept. 4, 2012 -
Independent Director ImmunoGen Inc Jan. 24, 2018 -
Independent Director Dare Bioscience Inc June 26, 2015 - July 19, 2017
Stuart Arbuckle's trades of Vertex Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-05-17 2024-05-15
PlS Planned sale
31,446 +25.2%
483.79
US$1,790,203 		31,446 +25.2% 483.79 US$1,790,203
2024-05-15 2024-05-15
PrS Proposed sale
70,526
29.34
US$1,094,089 		70,526 29.34 US$1,094,089
2024-02-27 2024-02-26
PlS Planned sale
17,940 +28.9%
277.76
US$3,070,610 		17,940 +28.9% 277.76 US$3,070,610
2024-02-26 2024-02-26
PrS Proposed sale
5,034
425.70
US$2,142,974 		5,034 425.70 US$2,142,974
2024-02-23 2024-02-21
PlS Planned sale
3,603 -5.7%
421.77
US$1,519,637 		3,603 -5.7% 421.77 US$1,519,637
2024-02-21 2024-02-21
PrS Proposed sale
3,603
421.77
US$1,519,637 		3,603 421.77 US$1,519,637
2024-02-21 2024-02-20
PlS Planned sale
4,804 -7.1%
420.79
US$2,021,475 		4,804 -7.1% 420.79 US$2,021,475
2024-02-20 2024-02-20
PrS Proposed sale
4,804
420.79
US$2,021,475 		4,804 420.79 US$2,021,475
2024-02-13 2024-02-12
PlS Planned sale
4,295 -5.4%
420.24
US$1,804,931 		4,295 -5.4% 420.24 US$1,804,931
2024-02-12 2024-02-12
PrS Proposed sale
4,295
420.24
US$1,804,931 		4,295 420.24 US$1,804,931
2023-12-15 2023-12-13
PlS Planned sale
8,603 -13.2%
399.00
US$3,432,597 		8,603 -13.2% 399.00 US$3,432,597
2023-12-13 2023-12-13
PrS Proposed sale
8,603
399.00
US$3,432,597 		8,603 399.00 US$3,432,597
2023-06-20 2023-06-15
PlS Planned sale
8,603 -13.2%
349.00
US$3,002,447 		8,603 -13.2% 349.00 US$3,002,447
2023-06-15 2023-06-15
PrS Proposed sale
8,603
349.00
US$3,002,449 		8,603 349.00 US$3,002,449
2023-06-01 2023-05-30
PlS Planned sale
82 -0.1%
329.82
US$27,045 		82 -0.1% 329.82 US$27,045
2023-05-30 2023-05-30
PrS Proposed sale
82
329.82
US$27,045 		82 329.82 US$27,045
2023-02-28 2023-02-27
PlS Planned sale
800 -1.4%
288.92
US$231,136 		800 -1.4% 288.92 US$231,136
2023-02-28 2023-02-27
PlS Planned sale
400 -0.7%
287.59
US$115,036 		400 -0.7% 287.59 US$115,036
2023-02-28 2023-02-27
PlS Planned sale
3,834 -6.2%
287.16
US$1,100,971 		3,834 -6.2% 287.16 US$1,100,971
2023-02-24 2023-02-22
PlS Planned sale
200 -0.3%
296.31
US$59,262 		200 -0.3% 296.31 US$59,262
2023-02-24 2023-02-22
PlS Planned sale
394 -0.6%
295.38
US$116,380 		394 -0.6% 295.38 US$116,380
2023-02-24 2023-02-22
PlS Planned sale
1,378 -2.0%
294.29
US$405,532 		1,378 -2.0% 294.29 US$405,532
2023-02-24 2023-02-22
PlS Planned sale
300 -0.4%
292.86
US$87,858 		300 -0.4% 292.86 US$87,858
2023-02-24 2023-02-22
PlS Planned sale
129 -0.2%
291.84
US$37,647 		129 -0.2% 291.84 US$37,647
2023-02-22 2023-02-21
PlS Planned sale
736 -1.1%
294.58
US$216,811 		736 -1.1% 294.58 US$216,811
2023-02-22 2023-02-21
PlS Planned sale
1,100 -1.6%
293.74
US$323,114 		1,100 -1.6% 293.74 US$323,114
2023-02-22 2023-02-21
PlS Planned sale
545 -0.8%
292.77
US$159,560 		545 -0.8% 292.77 US$159,560
2023-02-22 2023-02-21
PlS Planned sale
21 -0.0%
291.01
US$6,111 		21 -0.0% 291.01 US$6,111
2023-02-16 2023-02-14
PlS Planned sale
400 -0.5%
300.89
US$120,356 		400 -0.5% 300.89 US$120,356
2023-02-16 2023-02-14
PlS Planned sale
1,734 -2.2%
300.09
US$520,356 		1,734 -2.2% 300.09 US$520,356
2023-02-16 2023-02-14
PlS Planned sale
2,003 -2.5%
299.13
US$599,157 		2,003 -2.5% 299.13 US$599,157
2023-02-16 2023-02-14
PlS Planned sale
560 -0.7%
298.14
US$166,958 		560 -0.7% 298.14 US$166,958
2023-02-16 2023-02-14
PlS Planned sale
901 -1.1%
296.85
US$267,462 		901 -1.1% 296.85 US$267,462
2023-02-16 2023-02-14
PlS Planned sale
800 -1.0%
295.84
US$236,672 		800 -1.0% 295.84 US$236,672
2023-02-14 2023-02-13
PlS Planned sale
835 -1.0%
300.13
US$250,609 		835 -1.0% 300.13 US$250,609
2023-02-14 2023-02-13
PlS Planned sale
1,779 -2.1%
299.26
US$532,384 		1,779 -2.1% 299.26 US$532,384
2023-02-14 2023-02-13
PlS Planned sale
2,028 -2.3%
298.42
US$605,196 		2,028 -2.3% 298.42 US$605,196
2023-02-14 2023-02-13
PlS Planned sale
245 -0.3%
296.44
US$72,628 		245 -0.3% 296.44 US$72,628
2022-08-17 2022-08-15
PlS Planned sale
6,948 -13.3%
305.38
US$2,121,780 		6,948 -13.3% 305.38 US$2,121,780
2022-08-17 2022-08-15
PlS Planned sale
6,990 -11.8%
304.67
US$2,129,643 		6,990 -11.8% 304.67 US$2,129,643
2022-08-17 2022-08-15
PlS Planned sale
2,339 -3.8%
303.78
US$710,541 		2,339 -3.8% 303.78 US$710,541
2022-08-17 2022-08-15
PlS Planned sale
400 -0.6%
302.55
US$121,020 		400 -0.6% 302.55 US$121,020
2022-08-17 2022-08-15
PlS Planned sale
4,242 -6.4%
301.61
US$1,279,430 		4,242 -6.4% 301.61 US$1,279,430
2022-08-17 2022-08-15
PlS Planned sale
1,254 -1.9%
300.30
US$376,576 		1,254 -1.9% 300.30 US$376,576
2022-08-12 2022-08-10
PlS Planned sale
9 -0.0%
302.01
US$2,718 		9 -0.0% 302.01 US$2,718